Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Buck

Showing results (211-220 of 400) with videos related to

Pageof 40
Sort By:
Journal of Internal Medicine|November 23, 2006
Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumoursS Krüger, A K Buck, N M Blumstein, et al.
BMC Cancer|April 19, 2014
Somatostatin receptor expression in Merkel cell carcinoma as target for molecular imagingKristina Buder, Constantin Lapa, Michael C Kreissl, et al.
Clinical Nuclear Medicine|January 27, 2022
Visualization of Tumor Heterogeneity in Advanced Medullary Thyroid Carcinoma by Dual-Tracer Molecular Imaging: Revealing the Theranostic Potential of SSTR- and PSMA-Directed EndoradiotherapyNatalie Hasenauer, Takahiro Higuchi, Barbara Deschler-Baier, et al.
Clinical Nuclear Medicine|February 13, 2024
Exploring Theranostic Avenues in Adrenocortical Carcinoma Using Chemokine Receptor and Prostate-Specific Membrane Antigen-Directed PET/CTStefanie Hahner, Takahiro Higuchi, Sebastian E Serfling, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 6, 2010
Cost-effectiveness of hybrid PET/CT for staging of non-small cell lung cancerJonas Schreyögg, Julia Weller, Tom Stargardt, et al.
Oncotargets and Therapy|June 13, 2014
Positron emission tomographic monitoring of dual phosphatidylinositol-3-kinase and mTOR inhibition in anaplastic large cell lymphomaNicolas Graf, Zhoulei Li, Ken Herrmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 13, 2021
DNA damage and repair in peripheral blood mononuclear cells after internal ex vivo irradiation of patient blood with <sup>131</sup>IS Schumann, H Scherthan, K Pfestroff, et al.
Molecular Imaging|January 6, 2022
The Number of Frames on ECG-Gated <sup>18</sup>F-FDG Small Animal PET Has a Significant Impact on LV Systolic and Diastolic Functional ParametersChristoph Eissler, Rudolf A Werner, Paula Arias-Loza, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 4, 2014
Impact of 11C-choline PET/CT on clinical decision making in recurrent prostate cancer: results from a retrospective two-centre trialFrancesco Ceci, Ken Herrmann, Paolo Castellucci, et al.
Clinical Nuclear Medicine|December 11, 2023
C-X-C Motif Chemokine Receptor 4-Targeted Radioligand Therapy in Hematological Malignancies-Myeloablative Effects, Antilymphoma Activity, and Safety ProfileNiklas Dreher, Anna-Lena Dörrler, Sabrina Kraus, et al.
Pageof 40

Showing results (211-220 of 400) with videos related to

Sort By:
Pageof 40
Journal of Internal Medicine|November 23, 2006
Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumoursS Krüger, A K Buck, N M Blumstein, et al.
BMC Cancer|April 19, 2014
Somatostatin receptor expression in Merkel cell carcinoma as target for molecular imagingKristina Buder, Constantin Lapa, Michael C Kreissl, et al.
Clinical Nuclear Medicine|January 27, 2022
Visualization of Tumor Heterogeneity in Advanced Medullary Thyroid Carcinoma by Dual-Tracer Molecular Imaging: Revealing the Theranostic Potential of SSTR- and PSMA-Directed EndoradiotherapyNatalie Hasenauer, Takahiro Higuchi, Barbara Deschler-Baier, et al.
Clinical Nuclear Medicine|February 13, 2024
Exploring Theranostic Avenues in Adrenocortical Carcinoma Using Chemokine Receptor and Prostate-Specific Membrane Antigen-Directed PET/CTStefanie Hahner, Takahiro Higuchi, Sebastian E Serfling, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 6, 2010
Cost-effectiveness of hybrid PET/CT for staging of non-small cell lung cancerJonas Schreyögg, Julia Weller, Tom Stargardt, et al.
Oncotargets and Therapy|June 13, 2014
Positron emission tomographic monitoring of dual phosphatidylinositol-3-kinase and mTOR inhibition in anaplastic large cell lymphomaNicolas Graf, Zhoulei Li, Ken Herrmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 13, 2021
DNA damage and repair in peripheral blood mononuclear cells after internal ex vivo irradiation of patient blood with <sup>131</sup>IS Schumann, H Scherthan, K Pfestroff, et al.
Molecular Imaging|January 6, 2022
The Number of Frames on ECG-Gated <sup>18</sup>F-FDG Small Animal PET Has a Significant Impact on LV Systolic and Diastolic Functional ParametersChristoph Eissler, Rudolf A Werner, Paula Arias-Loza, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 4, 2014
Impact of 11C-choline PET/CT on clinical decision making in recurrent prostate cancer: results from a retrospective two-centre trialFrancesco Ceci, Ken Herrmann, Paolo Castellucci, et al.
Clinical Nuclear Medicine|December 11, 2023
C-X-C Motif Chemokine Receptor 4-Targeted Radioligand Therapy in Hematological Malignancies-Myeloablative Effects, Antilymphoma Activity, and Safety ProfileNiklas Dreher, Anna-Lena Dörrler, Sabrina Kraus, et al.
Pageof 40